Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Myopia Treatment Market Size And Revenue Forecast Through 2030
The market for myopia treatments has experienced robust expansion of late, projecting a rise from $19.52 billion in 2025 to $21.38 billion in 2026, fueled by a compound annual growth rate of 9.5%. Factors contributing to this growth during the preceding period include heightened exposure to digital screens, an escalating incidence of myopia among children, restricted availability of preventative eye care, the foundational advancements in refractive surgery methods, and the initial uptake of vision correction devices.
The market for myopia treatments is projected for significant expansion in the upcoming years, reaching an estimated $30.38 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.2%. This projected increase over the forecast period is fueled by several key factors: heightened awareness surrounding myopia control therapies, advancements in laser treatment technologies, a surge in demand for orthokeratology, increased funding for ophthalmic research, and the integration of sophisticated diagnostic tools. Prominent trends anticipated during this timeframe include a greater acceptance of orthokeratology (ortho-k), a growing inclination towards refractive surgeries that are minimally invasive, escalating demand for myopia control lenses specifically for children, a rise in myopia cases linked to digital eye strain, and the wider implementation of preventive eye care awareness initiatives.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20892&type=smp
Myopia Treatment Market Expansion Drivers: What Is Shaping Future Growth?
The escalating amount of time individuals dedicate to digital screens is anticipated to be a significant catalyst for the expansion of the myopia treatment market. This phenomenon, known as screen time, encompasses the duration spent interacting with devices such as smartphones, tablets, computers, and televisions, and its growth is fueled by the proliferation of streaming platforms, amplified social media engagement, the increasing prevalence of remote work arrangements, and the widespread adoption of virtual meetings. Myopia treatments offer a crucial benefit by alleviating eye strain and discomfort that arise from extended screen exposure, thereby enhancing visual focus, promoting comfort, and refining clarity of vision. Illustrating this trend, data from the Centers for Disease Control and Prevention, a US governmental body, indicated that in October 2024, over the period spanning July 2021 to December 2023, a substantial 50.4% of adolescents aged 12–17 dedicated four or more hours daily to screen usage, whereas 22.8% clocked in three hours, 17.8% spent two hours, 6.1% used screens for one hour, and a mere 3.0% engaged with screens for less than an hour each day, consequently underscoring the direct correlation between heightened screen time and the burgeoning growth within the myopia treatment sector.
Myopia Treatment Market Segment Performance And Strategic Opportunities
The myopia treatment market covered in this report is segmented –
1) By Type: Simple Myopia, High Myopia, Pathological Myopia
2) By Treatment: Eyeglasses, Contact Lenses, Refractive Surgery, Laser-Assisted In Situ Keratomileusis (LASIK), Photorefractive Keratectomy (PRK), Orthokeratology (Ortho-K)
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Direct Tender, Retail Sales, Other Distribution Channels
5) By End-User: Physician Offices, Reference Laboratories, Other End-Users
Subsegments:
1) By Simple Myopia: Mild Myopia, Moderate Myopia
2) By High Myopia: Severe Myopia, Very Severe Myopia
3) By Pathological Myopia: Degenerative Myopia, Malignant Myopia
Myopia Treatment Market Strategic Trends: What Is Defining The Next Phase Of Growth?
In the myopia treatment sector, prominent players are dedicating resources to innovative solutions, including sophisticated optical biometers, to refine diagnostic accuracy and personalize therapeutic strategies. These instruments employ light-based technology to ascertain ocular dimensions like axial length and corneal topography, facilitating the diagnosis and ongoing observation of eye health. Illustrating this trend, NIDEK Co., Ltd., a notable Japanese ophthalmic equipment producer, introduced the AL-Scan M and MV-1 in February 2023. The AL-Scan M distinguishes itself with integrated 3D auto-tracking and auto-shot functionalities, streamlining measurements with an ease akin to autorefractors and thereby boosting patient handling efficiency, especially for pediatric cases. This device is meticulously designed for exact axial length quantification, a vital metric for tracking the advancement of myopia. Furthermore, it offers smooth compatibility with the MV-1 Myopia Viewer software, aiding in the review of treatment histories and patient engagement patterns.
Myopia Treatment Market Key Players: Which Companies Shape Industry Competition?
Major companies operating in the myopia treatment market are Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Johnson & Johnson Vision Care Inc., CooperVision Inc., Menicon Co. Ltd., Topcon Healthcare Inc., Essilor Ltd., NIDEK CO. LTD., SightGlass Vision Inc., SCHWIND eye-tech-solutions GmbH, Visioneering Technologies Inc., MEDMONT INTERNATIONAL PTY LTD., Vyluma Inc., Haag-Streit Holding AG, NovaSight Ltd., Euclid Vision Corporation, Treehouse Eyes LLC, Sydnexis Inc., Neurobit Technologies Co. Ltd., Kubota Pharmaceutical Holdings Co. Ltd.
Access The Complete Myopia Treatment Market Report:
https://www.thebusinessresearchcompany.com/report/myopia-treatment-global-market-report
Myopia Treatment Market Largest Region By Revenue And Market Share
Asia Pacificwas the largest region in the myopia treatment market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the myopia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









